Save Stocks
Viewing
Filtered By
Ordered By
Questcor's Acthar Gel: Clinical Usage Suggests Efficacy
7/10/2014 3:28:00 AM - Seeking Alpha


Summer Slog Likely To Keep A Lid On Further Stock Gains
7/7/2014 3:10:00 AM - Seeking Alpha


What Stocks Top Funds Are Buying Now
7/2/2014 6:09:00 PM - Investor's Business Daily


Questcor And Mallinckrodt: The Good, The Bad, And The Ugly
6/30/2014 6:07:00 PM - Seeking Alpha


Hey Mallinckrodt, Pay Close Attention - UnitedHealth Just Slammed Questcor's Acthar
6/30/2014 11:53:00 AM - Seeking Alpha


Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for June 27, 2014
6/26/2014 8:00:03 AM - NASDAQ.com News


The FDA Owes Us An Answer On Questcor's Acthar
6/25/2014 1:49:00 PM - Seeking Alpha


QTR's Mid-Year Portfolio Recap
6/18/2014 12:13:00 PM - Seeking Alpha


Questcor: Another Serious Reason To Be A Skeptic
6/17/2014 9:27:00 AM - Seeking Alpha


Questcor's 'Buyout' Could Fall Through
6/6/2014 3:53:00 PM - Seeking Alpha


IWO, AYI, SUNE, QCOR: Large Outflows Detected at ETF
6/6/2014 9:50:49 AM - BNK Invest


Interesting QCOR Put And Call Options For July 3rd
5/22/2014 9:55:47 AM - BNK Invest


Questcor Pharmaceuticals Larger Than S&P 500 Component Owens-Illinois
5/19/2014 3:37:55 PM - BNK Invest


Questcor (QCOR) is Overbought: Is A Drop Coming? - Tale of the Tape
5/15/2014 8:00:43 AM - Zacks.com


Industry Ranks May 2014
5/11/2014 5:45:00 AM - Seeking Alpha


Questcor Misses on Earnings & Revs in Q1 - Analyst Blog
4/29/2014 10:40:01 AM - Zacks.com


Cytokinetics' Tirasemtiv Misses Primary Endpoint - Analyst Blog
4/28/2014 2:22:01 PM - Zacks.com


In Line Q3 Loss at ImmunoGen - Analyst Blog
4/28/2014 9:40:01 AM - Zacks.com


Synergy Pharmaceuticals (SGYP) Jumps: Stock Up 10.9% - Tale of the Tape
4/25/2014 8:39:01 AM - Zacks.com


OncoGenex Gains Fast Track Status for Custirsen - Analyst Blog
4/24/2014 5:50:01 PM - Zacks.com


UCB Sales Rise in Q1 - Analyst Blog
4/24/2014 3:30:01 PM - Zacks.com


Eli Lilly to Acquire Novartis' Animal Health Biz - Analyst Blog
4/22/2014 4:40:01 PM - Zacks.com


Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog
4/15/2014 4:25:01 PM - Zacks.com


Flamel Technologies (FLML) in Focus: Stock Slumps 13.5% - Tale of the Tape
4/15/2014 7:54:01 AM - Zacks.com


Pharmacyclics (PCYC) Crumbles: Stock Falls by 7.7% - Tale of the Tape
4/14/2014 10:00:01 AM - Zacks.com